18504-27-3 Usage
Description
1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is a chemical compound that serves as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It is a nitroimidazole derivative, characterized by the presence of a nitro group and an imidazole ring in its structure. 1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is recognized for its antimicrobial, antiparasitic, and potential anti-cancer properties, as well as its use as a radioprotective agent, making it a versatile molecule in the medical and pharmaceutical fields.
Uses
Used in Pharmaceutical Synthesis:
1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique structure allows for the development of new compounds with targeted therapeutic effects.
Used in Antimicrobial Applications:
In the field of infectious diseases, 1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is used as an antimicrobial agent to combat bacterial infections. Its activity against a range of bacteria makes it a valuable asset in the development of new antibiotics.
Used in Antiparasitic Applications:
1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole is also utilized as an antiparasitic agent, targeting infections caused by parasites. Its effectiveness against various parasites contributes to its potential use in treating a wide array of parasitic diseases.
Used in Anticancer Applications:
1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole has been studied for its potential anti-cancer properties, making it a candidate for the development of novel cancer treatments. Its ability to target cancer cells and potentially inhibit their growth and proliferation is of significant interest in the field of oncology.
Used in Radioprotective Applications:
1-(2-bromoethyl)-2-methyl-4-nitro-1H-imidazole has been explored for its use as a radioprotective agent, which could help protect cells and tissues from the damaging effects of radiation. This application could be particularly useful in the context of cancer treatments, where radiation therapy is a common approach.
Check Digit Verification of cas no
The CAS Registry Mumber 18504-27-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,5,0 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 18504-27:
(7*1)+(6*8)+(5*5)+(4*0)+(3*4)+(2*2)+(1*7)=103
103 % 10 = 3
So 18504-27-3 is a valid CAS Registry Number.
18504-27-3Relevant articles and documents
Crystal Habit Modification of Metronidazole by Supramolecular Gels with Complementary Functionality
Jayabhavan, Sreejith Sudhakaran,Steed, Jonathan W.,Damodaran, Krishna K.
, p. 5383 - 5393 (2021)
A series of bis(urea) compounds with complementary functional groups similar to the pharmaceutical drug metronidazole and a structural isomer isometronidazole have been synthesized. The gelation properties of these compounds were studied in various solvent/solvent mixtures. The mechanical strength of the isomeric gelators was compared using rheology, and the morphologies of the xerogels were analyzed by scanning electron microscopy. These gels were used as media for metronidazole crystallization resulting in a marked habit modification of the metronidazole crystals in the drug-mimicking gels. However, crystallization in the nonmimetic isomeric gel resulted in morphologies similar to the solution state. These results indicate that the drug-mimetic gels interact with the surface of the drug crystal giving rise to new morphologies.
